![Insights from 2023 ASH Annual Meeting](http://media.vumedi.com/thumbs/channel_logo/2023/12/d8f4a042-951d-471d-8892-527b15ad5587.png.200x0_q85.png)
Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
The Future Paradigm of HMA + Ven or Targeted Agents in AML: Sequencing and Triplet Combinations
By
Insights from 2023 ASH Annual Meeting
FEATURING
Justin Watts
By
Insights from 2023 ASH Annual Meeting
FEATURING
Justin Watts
140 views
January 17, 2024
Login to view comments.
Click here to Login
Leukemia